03/15/2024 3:42 PM | Akero Therapeutics (Issuer) Rolph Timothy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/15/2024 3:42 PM | Akero Therapeutics (Issuer) Young Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/15/2024 3:43 PM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/15/2024 3:44 PM | Akero Therapeutics (Issuer) White William Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/15/2024 3:45 PM | Akero Therapeutics (Issuer) Yale Catriona (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/15/2024 9:08 AM | Akero Therapeutics (Subject) GENERAL ATLANTIC, L.P. (Filed by)
| Form SC 13G | |
03/06/2024 7:13 PM | Akero Therapeutics (Issuer) Yale Catriona (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
03/06/2024 7:14 PM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 4:25 PM | Akero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/06/2024 4:16 PM | Akero Therapeutics (Filer)
| Form 424B5 | |
03/05/2024 4:16 PM | Akero Therapeutics (Issuer) Young Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 4:30 PM | Akero Therapeutics (Subject) Cheng Andrew (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024 6:55 AM | Akero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/29/2024 3:42 PM | Akero Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/29/2024 6:30 AM | Akero Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/29/2024 6:15 AM | Akero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 1:19 PM | Akero Therapeutics (Subject) PFIZER INC (Filed by)
| Form SC 13G/A | |
02/14/2024 6:06 AM | Akero Therapeutics (Subject) RTW INVESTMENTS, LP (Filed by)
| Form SC 13G | |
02/13/2024 8:40 PM | Akero Therapeutics (Subject) Avidity Partners Management LP (Filed by)
| Form SC 13G/A | |
02/13/2024 5:30 PM | Akero Therapeutics (Subject) ALKEON CAPITAL MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
02/13/2024 10:31 AM | Akero Therapeutics (Subject) JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
02/07/2024 6:23 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by) Akero Therapeutics (Subject)
| Form SC 13G/A | |
01/25/2024 8:36 AM | Akero Therapeutics (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
12/29/2023 7:30 PM | Akero Therapeutics (Issuer) Young Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/29/2023 5:07 PM | Akero Therapeutics (Subject) Young Jonathan (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2023 7:49 PM | Akero Therapeutics (Issuer) Yale Catriona (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2023 7:37 PM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2023 7:39 PM | Akero Therapeutics (Issuer) Young Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2023 7:40 PM | Akero Therapeutics (Issuer) White William Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2023 7:29 PM | Akero Therapeutics (Issuer) Rolph Timothy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2023 6:08 AM | Akero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/12/2023 3:43 PM | Akero Therapeutics (Issuer) Young Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2023 3:43 PM | Akero Therapeutics (Issuer) White William Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2023 3:35 PM | Akero Therapeutics (Issuer) Lamy Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2023 3:38 PM | Akero Therapeutics (Issuer) Rolph Timothy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2023 3:26 PM | Akero Therapeutics (Issuer) Yale Catriona (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 7:59 PM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 8:06 PM | Akero Therapeutics (Issuer) Graham G. Walmsley (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 7:37 AM | Akero Therapeutics (Issuer) Graham G. Walmsley (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2023 4:30 PM | Akero Therapeutics (Issuer) Young Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/13/2023 4:37 PM | Akero Therapeutics (Issuer) White William Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Central Bank Gold Heist In Progress (Ad) When central banks buy gold…
The rich buy right along with them.
And central banks are buying at breakneck pace.
Last year… 1,037 tons.
Just 45 tons less than the record set two years ago. That's why we have released our Free Precious Metals Investment Guide. |
11/13/2023 6:33 AM | Akero Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/13/2023 6:15 AM | Akero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/10/2023 7:04 AM | Akero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/04/2023 7:33 PM | Akero Therapeutics (Issuer) Young Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/04/2023 7:41 PM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/02/2023 5:17 PM | Akero Therapeutics (Subject) Young Jonathan (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2023 5:21 PM | Akero Therapeutics (Subject) Cheng Andrew (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/25/2023 7:28 PM | Akero Therapeutics (Issuer) Young Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/25/2023 7:30 PM | Akero Therapeutics (Issuer) Rolph Timothy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/25/2023 7:31 PM | Akero Therapeutics (Issuer) Yale Catriona (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/25/2023 7:31 PM | Akero Therapeutics (Issuer) White William Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/25/2023 7:36 PM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/18/2023 5:48 PM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/30/2023 6:04 PM | Akero Therapeutics (Issuer) Yale Catriona (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/30/2023 6:04 PM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/10/2023 8:02 PM | Akero Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/11/2023 5:09 AM | Akero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/03/2023 3:13 PM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/01/2023 6:52 PM | Akero Therapeutics (Issuer) Graham G. Walmsley (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/06/2023 7:44 PM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2023 12:07 PM | Akero Therapeutics (Subject) Cheng Andrew (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/27/2023 6:12 PM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2023 5:00 PM | Akero Therapeutics (Issuer) Xu Yuan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2023 4:52 PM | Akero Therapeutics (Issuer) Heyman Tomas J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2023 4:55 PM | Akero Therapeutics (Issuer) Henderson Jane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2023 4:58 PM | Akero Therapeutics (Issuer) Judy Chou (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2023 4:39 PM | Akero Therapeutics (Issuer) Iwicki Mark T (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2023 4:48 PM | Akero Therapeutics (Issuer) Harrison Seth Loring (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2023 4:48 PM | Akero Therapeutics (Issuer) Graham G. Walmsley (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2023 4:29 PM | Akero Therapeutics (Subject) Rolph Timothy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/26/2023 3:02 PM | Akero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/23/2023 7:06 PM | Akero Therapeutics (Issuer) Yale Catriona (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/22/2023 4:20 PM | Akero Therapeutics (Issuer) White William Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/21/2023 4:54 PM | Akero Therapeutics (Issuer) Heyman Tomas J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/21/2023 4:46 PM | Akero Therapeutics (Issuer) Rolph Timothy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/21/2023 4:47 PM | Akero Therapeutics (Issuer) Henderson Jane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 5:00 PM | Akero Therapeutics (Subject) Heyman Tomas J. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/16/2023 4:41 PM | Akero Therapeutics (Subject) Henderson Jane (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/16/2023 3:22 PM | Akero Therapeutics (Subject) Rolph Timothy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/15/2023 8:38 PM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 8:41 PM | Akero Therapeutics (Issuer) White William Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 8:29 PM | Akero Therapeutics (Issuer) Yale Catriona (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 8:35 PM | Akero Therapeutics (Issuer) Young Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 8:35 PM | Akero Therapeutics (Issuer) Rolph Timothy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 8:26 PM | Akero Therapeutics (Issuer) Graham G. Walmsley (Reporting)
| Form 4/A | |
06/05/2023 5:23 PM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2023 7:05 AM | Akero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/23/2023 8:55 PM | Akero Therapeutics (Issuer) Graham G. Walmsley (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2023 6:30 AM | Akero Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/15/2023 6:19 AM | Akero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
They said crypto was dead. It went up 100X. (Ad) Bitcoin’s haters are out again.
Despite the price doubling in the last six months alone…
That hasn’t stopped the experts from piling on.
Warren Buffett’s right-hand man Charlie Munger called crypto investors “idiots” in one of his last interviews.
JPMorgan CEO Jamie Dimon, recently called Bitcoin a “pet rock” and “a hyped-up fraud.”
But when it comes to cryptos, these are exactly the people you shouldn’t listen to.
They’ve predicted crypto’s demise for years. There are five coins you must take a look at right away. |
05/03/2023 7:28 PM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/10/2023 3:59 PM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by) Akero Therapeutics (Subject)
| Form SC 13G | |
04/05/2023 3:55 PM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2023 12:37 PM | Akero Therapeutics (Subject) Cheng Andrew (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/29/2023 4:20 PM | Akero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |